FM Flashcards

1
Q

What questions should be asked on a back pain history?

A

1) Where is the pain worst?
- Differentiate between back/buttock dominant and leg pain

2) Is the pain constant?
- If yes, need to rule out red flags

3)What increases your typical pain?

4) Is there anything you cannot do now because of your pain?
- Trying to screen for yellow flags to help ascertain psychosocial RFs

5) Have you had any unexpected accidents with your bowel or bladder since back pain started?
- Rule out Acute Cauda Equina

6) If age of onset <45 are you experiencing morning stiffness in your back >30mins?
- Screen for systemic inflammatory arthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Back Pain Patterns

A
  1. Back Dominant: worse with flex ion (+/-extension)>Disc Pain ex. Degenerative disc
  2. Back Dominant: worse with extension> Facet Joint Pain ex. Facet joint OA
  3. Leg Dominant: worse with any movement >Compressed Nerve Pain ex. Herniated disc
  4. Leg Dominant: worse with standing and walking> Neurogenic Claudication/Spinal Stenosis

If doesn’t fit these patterns, likely non-mechanical back pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Acute Cauda Equina involves…

A

Urinary retention followed by insensible urinary overflow
Unrecognized fecal incontinence
Loss of saddle/perineal sensation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Initial pharm treatment of mechanical back pain involves…

A

Acetaminophen followed by NSAIDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Back Pain Red Flags

A

“NIFTI”
Neurological: Diffuse motor/sensory loss, progressive neurological deficits, Claudia Equina syndrome

Infectious: Fever, IVDU, immunosuppression

Fracture: Trauma, OP risk, fragility #

Tumour: Hx of malignancy and constitutional sx

Inflammatory: chronic back pain >3mo, age <45, >30min morning stiffness, improves with activity, disproportionate night pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Back Pain Red Flag investigations

A

“NIFTI”
Neurological—MRI

Infectious—MRI + X-ray

Fracture—X-ray +/- CT

Tumour—MRI + X-ray

Inflammatory—Rheum Consult

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Yellow flag questions to ask about back/neck pain

A

1) Do you think your pain will improve or worsen?
2) Do you think you would benefit from activities, movement or exercise?
3) How are you emotionally coping with back pain?
4) What tx or activities do you think will help you recover?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Systemic inflammatory arthritis screen for back pain (if morning stiffness >30 min)

A
  • Age <45
  • Insidious Onset
  • Improves with exercise
  • No improvement with rest
  • Pain at night (improves with getting up)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Non mechanical back pain can be related to:_____ or ______

A

Spine or Non-Spine

Consider referred pain from internal organs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

3 locations that mechanical neck pain can present

A
  1. Neck
  2. Shoulder
  3. Arm
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What questions should be asked on a Neck Pain History?

A

1) Where is the pain worse?
- Neck vs Shoulder vs Arm

2) Is the pain constant?
- Rule out red flag sx

3) Assess for potential cardiac etiology
- Chest pain, Dizziness, SOB

4) Assess for associated symptoms and changes
- Surgical evaluation to r/o degenerative cervical myelopathy if changes in gait/walking/balance, fine motor issues, new onset tingling/numbness in arms/hands

5) Did neck pain begin with trauma, accident or fall?
- Check for concussion symptoms

6) Is there anything you cannot do now that you could before pain?
- Assess yellow flags, psychosocial risks

7) If age <60 at onset, do you have morning neck stiffness >30mins?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Neck Pain Red Flags

A

“NIFTI”
Neurological: progressive neurological deficit, cervical cord compression, demyelinating process

Infectious: Fever, IVDU, Immunosuppresion, Meningismus

Fracture: Trauma, OP risks, fragility fractures

Tumour: History of malignancy and constitutional sx

Inflammatory: RA, PMR, GCA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Neck Pain Red Flag Investigations

A

“NIFTI”
Neurological: MRI

Infectious: MRI + Xray

Fracture: Xray +/- CT

Tumour: MRI + Xray

Inflammatory: Rheum Consult

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Systemic Inflammatory arthritis screen for neck pain (if morning stiffness >30 min) involves….

A
  • Age <60
  • Insidious Onset
  • Improves with exercise
  • No improvement with rest
  • Pain at night (improves with getting up)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Treatment of acute/subacute back pain (<12 weeks) involves:

A

1) Patient education
2) Prescribe self-care (ex. Alternating cold and heat)
3) Encourage early return to work
4) Physical activity/exercise
5) Consider analgesics
6) F/U in 1-6 weeks, if not improving consider referral ex. Physical therapist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

In what order should analgesics be considered for acute/subacute back pain?

A

Acetaminophen> NSAIDs> Muscle Relaxants> Opioids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Recovery position/Starter exercise for Pattern 1 back pain

A

Prone extension; 10 reps TID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Recovery position/Starter exercise for Pattern 2 back pain

A

Seated back flexion; small frequent reps throughout day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Recovery position/Starter exercise for Pattern 3 back pain

A

Z position; advise frequent position changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Recovery position/Starter exercise for Pattern 4 back pain

A

Rest in seated position; advise frequent sitting breaks and support with walking/standing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Treatment of chronic back pain (>12 weeks involves)

A

1) Prescribing exercises
2) Analgesics
3) Community-based referrals ex. CBT
4) Consider additional options ex. Massage, aqua therapy
5) If mod-severe: opioids, consider additional referrals ex. Multidisciplinary pain program

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

In what order should analgesics be considered for chronic back pain?

A

Acetaminophen> NSAIDS> TCAs or weak opioids> Tramadol> Strong opioids

Cyclobenzaprine can be used for flare ups

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Muscle relaxants not recommended for _____neck dominant pain

A

Chronic neck dominant pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Treatment of acute neck dominant pain (<3 months):

A

Educate, Reassure, Encourage early return to work, Independent exercises, consider referral to activity therapy as needed, 1-6 to sessions, analgesics (acetaminophen, NSAIDs, add/replace with cyclobenzaprine short term)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Treatment of chronic neck dominant pain (>3 months):
Educate, Reassures, Active Rehab Therapy, 6-12 sessions of treatment, analgesics (acetaminophen, NSAIDs, add/replace with Antidepressants or Antiepileptics)
26
Treatment of acute arm dominant pain (<3 months):
Educate, Reassure, Encourage early return to work, Independent exercises, consider referral to activity therapy as needed, 1-6 to sessions, frequent rest positions, traction, analgesics (acetaminophen, NSAIDs, Opioids, Cyclobenzaprine, add/replace with antidepressants, antiepileptics, consider methylprednisolone/dex for severe radiculopathy)
27
Treatment of chronic neck dominant pain (>3 months):
Educate, Reassures, Active Rehab Therapy, 6-12 sessions of treatment, frequent rest positions, traction, analgesics (acetaminophen, NSAIDs, opioids add/replace with Antidepressants or Antiepileptics)
28
Components of Neck Pain Physical Examination Include:
Standing-Gait and Neck Posture Sitting-Lymph node exam, Neck AROM, Shoulder AROM, Spurling’s Compression test, DTR (biceps and triceps), dermatomes/myotomes Supine-Cervical distraction test (+if arm pain relieved), UMN screening (Babinski and Hoffman)
29
Components of Back Pain Physical Examination Include:
Gait- heel walk, toe walk Standing- movements in flexion, movements in extension, trendelenberg, repeated toe raises Sitting-Patellar reflex, quad power, ankle dorsiflexion power, great toe extension power, great toe flexion power, plantar response Kneeling-Ankle reflex test Supine-Passive straight less raise, Passive Hip ROM Prone-Femoral nerve stretch, Glut max power, saddle sensation, passive back extension
30
If neuro exam normal then leg pain is____
Referred
31
+ Straight leg test with reproduction of leg pain and possible abnormal neuro signs indicates:
Radicular (Nerve) Pain
32
Minimum requirements of physical exam for back pain:
Movement testing in flexion and extension, patellar reflex, Great toe flexion and extension power, plantar response, UMN test, Passive SLR, Saddle sensation testing
33
Differential for cognitive impairment:
Normal aging, Depression, MCI, Delirium
34
What distinguishes MCI from Dementia?
Memory impairment with preservation of other cognitive abilities, slight or absent functional impairment, does not meet dementia criteria
35
Criteria for major neurocognitive disorder:
1) Evidence of significant cognitive decline in one or more domain based on concern knowledgeable informant/the individual and a substantial impairment in cognitive function (as documented on a formal test or clinical assesssment) 2) Impacting independence of everyday activities 3) Not in the context of delirium 4) Not better explained by another mental disorder
36
RFs for secondary causes of dementia include:
CVD, Afib, CVA, DM, Dyslipidemia, Head Trauma, HT, Family Hx of early dementia
37
What physical exams should be performed to evaluate for secondary causes of dementia?
BP, Vision, Hearing, CV, Neuro
38
Which lab investigations should be ordered in working up secondary causes of dementia?
CBC, lytes, Cr, TSH, Glucose, B12, Ca
39
List indications for performing CT head in working up secondary causes of dementia?
Age <60, Rapid onset, Unexplained decrease in function, Unexplained neuro symptoms, Dementia <2 yrs, Vascular disease RFs, History of CA, bleeding disorder or anticoagulant use, Head trauma, Urinary incontinence and/or gait disorder early in illness, Gait disorder, Unusual Symptoms
40
What is expected yearly decline in MMSE?
1-2 points per year with mild (21-26 score) and 2-4 with moderate (10-20)
41
Which two classes of drugs are used to treat dementia?
Cholinesterase inhibitors (Donepazile, Rivastigmine, Galantamine) and NMDA receptor antagonists (Memantine)
42
Cholinesterase inhibitors are used in ____
Mild-Mod dementia
43
NMDA receptor antagonists are used in ____
Mod-Severe AD
44
Side effects of cholinesterase inhibitors include:
GI upset, headache, dizziness
45
Name 3 of the contraindications to cholinesterase inhibitors:
Sick sinus syndrome, severe renal/hepatic impairment, seizure disorder
46
Side effects of NMDA receptor antagonists include:
Constipation, dizziness, headache, anxiety, confusion
47
Skills for MI are:
OARS Open ended questions Affirmations Reflective listening Summary statements
48
Spirit of MI involves:
PACE Partnership Acceptance Compassion Evocation
49
Types of "change talk" include
DARN CAT ``` Prepatory Desire to change Ability to change Reasons for change Need to change ``` Mobilizing Commitment Activations Taking steps
50
Patients with these conditions are at elevated CKD risk:
HTN, DM, CVD (age 60-75)
51
Lab tests to be ordered in CKD workup
eGFR | Urine ACR
52
If initial eGFR in CKD workup <60 then...
Repeat test in 3 months
53
If initial Urine ACR in CKD workup is 3 or higher then...
Repeat 2 more times over next 3 months (2/3 random ACRs must be elevated)
54
What should always be considered in CKD workup prior to retested eGFR and Urine ACR?
Reversible causes ex. NSAIDS, BPH/Retention
55
Diagnosing CKD: 3 months after initial tests, eGFR is >60 and ACR <3. This means that...
Patient does not have CKD. | If DM, retest annually
56
Diagnosing CKD: 3 months after initial tests eGFR is 30-59 and/or ACR 3-60. This means that...
Patient has CKD, requires management.
57
Diagnosing CKD: 3 months after initial tests eGFR is <30 or ACR >60. This means that...
Patient has CKD. Consider Nephro referral.
58
If eGFR <30 what tests should you order?
Urine R+M, lytes, Ca, Ph, Alb, PTH
59
If ACR >60 what tests should you order?
Urine R+M and lytes
60
If 3 months after initial tests eGFR is 30-59 and/or ACR 3-60, which additional investigations should be ordered and how often should eGFR and ACR be monitored?
Order lytes and urine R+M. Follow eGFR and urine ACR every 6 months (if eGFR stable after 2 years follow up yearly).
61
If 3 months after initial tests eGFR is 30-59 and/or ACR 3-60, what are some reasons to refer to Nephro?
eGFR decline ≥ 5 within six months eGFR < 30 or ACR > 60 eGFR < 45 and ACR between 30 to 60 on 2 occasions 3 or more moths apart Inability to manage blood pressure Significant potassium disorder, RBC casts, hematuria
62
What are three streams of management that should be implemented in patients with CKD?
1. Modification of CV Risk Factors - Lifestyle, smoking cessation - Start Statin if: age >18 with DM, Age 50 or greater w/o DM, age 18-49 w/o DM but known CAD, prior stroke, or FRS >10% 2. Minimize further kidney injury - Avoid nephrotoxins if possible - Sick Day Meds 3. Measures to slow CKD progression - BP and RAAS blockade with ACE or ARB
63
Vertigo is a _____ sensation of one's surroundings or of one's self
Rotatory
64
Classic vestibular symptoms include
1. Continuous dizziness or vertigo 2. N/V 3. Nystagmus and gait instability 4. Head motion intolerance
65
Two features in a dizziness history that help to narrow differential.
Episodic vs Continuous Triggered vs Spontaneous
66
Triggered Episodic Vertigo (lasting seconds to hours)> Perform ______> +ive means ____, -ive means______.
Triggered Episodic Vertigo > Perform Dix-Hallpike> +ive means BPPV (posterior), -ive means ?orthostatic hypotension
67
Spontaneous Episodic Vertigo (lasting seconds to days) associated with hearing loss =
Meniere's
68
Spontaneous Episodic Vertigo (lasting seconds to days) associated with migraine
Vestibular Migraine
69
Spontaneous Episodic Vertigo (lasting seconds to days) associated with psych sx
Panic attack, Psych Condition
70
Examination for episodic vertigo
Dix-Hallpike
71
Examination for continuous vertigo
HINTS exam
72
Continuous vertigo lasting days to weeks could be associated with these precipitants
Barotrauma or Toxin (meds)
73
Spontaneous Continuous Vertigo with HINTS exam showing peripheral features, dx is....
Vestibular Neuritis
74
Spontaneous Continuous Vertigo with HINTS exam showing central features, dx is....
Stroke/TIA
75
HINTS exam findings for peripheral cause of continuous vertigo
HI: Corrective Saccade N: Unidirectional horizontal nystagmus TS: No deviation of covered eye
76
HINTS exam findings for central cause of continuous vertigo
HI: No corrective saccade N: Bidirectional horizontal nystagmus, or vertical or torsional nystagmus TS: Vertical deviation of covered eye
77
What is Benign Paroxysmal | Positional Vertigo?
``` Transient triggered (head motion) episodes of vertigo caused by dislodged canaliths in the semicircular canals ```
78
What is Vestibular Neuritis
Spontaneous (no triggers) episodic vertigo caused by inflammation of the vestibular nerve or labyrinth organs; usually from a viral infection
79
What is Meniere’s Disease
Spontaneous episodes of vertigo associated with unilateral hearing loss caused by excess endolymphatic fluid pressure in the inner ear
80
What is Otosclerosis
Spontaneous episodes of vertigo caused by abnormal bone growth in the middle ear and associated with conductive hearing loss
81
What is Vestibular Migraine
Spontaneous episodes of vertigo associated with migraine headaches
82
Cerebrovascular | Disease causes vertigo by...
Continuous spontaneous episodes of vertigo caused by arterial occlusion or insufficiency, especially affecting the vertebrobasilar system
83
Cerebellopontine | Angle
Continuous spontaneous episodes of dizziness caused by vestibular schwannoma (acoustic neuroma) > meningioma > others
84
Tx for BPPV
Epley
85
Tx for Meniere's
Salt restriction Diuretics Vestibular suppressants/antiemetics Betahistine
86
Tx for vestibular neuritis
Vestibular suppressants (antibistamine, antiemetics, benzos) Vestibular rehab Can consider steroids
87
Diagnostic criteria for Meniere's
1) 2 episodes of spontaneous rotational vertigo lasting min. 20 mins 2) SNHL 3) Tinnitus and/or aural fullness
88
What are the 4 D's of Vertebrobasilar Insufficiency
Drop Attacks Dysarthria Dizziness Diplopia
89
Tx for vertebrobasilar insufficiency in the context of vertigo
Antiplatelets and reduce cerebrovascular risk factors
90
Examples of ototoxic meds
Aminoglycosides and Furosemide
91
When is imaging indicated in vertigo work up?
When there is any abnormal neuro findings, including asymetric or unilateral hearing loss . Need CT (CT/CTA) or MRI (MR/MRA).
92
30/20/10 rule for orthostatic hypotension
HR Increase 30 bpm SBP decrease 20mmHg DBP decrease 10mmHg
93
What physical exam maneuvers should be included in vertigo workup?
1) Orthostatic BP 2) Cardiac 3) Neuro 4) Nystagmus 5) Dix-Hallpike
94
Which imaging modality is best for diagnosis in vertigo?
MRI as it can visualize the posterior fossa better than CT
95
What is Acute labyrinthitis
Inflammation of the labyrinthine organs caused by viral or bacterial infection Acute vestibular neuronitis (vestibular neuritis)* Inflammation of the vestibular nerve, usually caused by viral infection
96
What is Cholesteatoma
Cyst-like lesion filled with keratin debris, most often involving the middle ear and mastoid
97
What is Herpes zoster oticus (Ramsay | Hunt syndrome)
Vesicular eruption affecting the ear; caused by reactivation of the varicella-zoster virus
98
What is Perilymphatic fistula
Breach between middle and inner ear often caused by trauma or excessive straining
99
What are some red flags on a cough/dyspnea history?
Weight Loss Hemoptysis Fevers/Night Sweats Travel/TB exposure Occupational Hazards
100
Signs of respiratory distress
- Tachypnea - Pursed lip breathing - Accessory muscle use - Tripod position - Wheezing, audible breathing
101
4 acute causes of cough/dyspnea
1. Infectious 2. Post-Viral 3. Airway Irritants 4. Exacerbation of Chronic Illness
102
Tx for post-viral cough
inhaled bronchodilators +/- ICS
103
9 chronic causes of cough/dyspnea
1. Asthma 2. COPD 3. HF 4. Infectious (TB) 5. Post-nasal drip/rhinitis 6. Bronchiectasis 7. GERD 8. Medication (ACEi) 9. Lung Cancer
104
Presentation of post-nasal drip/rhinitis may include
Nasal discharge Nasopharygeal secretions Throat Clearing Sensation of dripping down throat Nasopharyngeal Cobblestoning
105
Tx of post-nasal drip/rhinitis may include
Oral antihistamines Oral decongestants Intranasal corticosteroids Intranasal Ipratropium bromide Leukotriene receptor antagnoists Abx as indicated
106
Presentation of GERD may include
Epigastric burning, bitter taste, cough, belching, bloating, early satiety, regurgitation, norcturnal symptoms, improvement with food (ulcer), dysmotility (worse with food)
107
Tx of GERD may include
Lifestyle Changes H2 blocker or PPI or antacid
108
Bronchiectasis may be ____ or ____
Focal (often from prolonged or sever LRTI) Multifocal (may be secondary to MAC)
109
Red flags for bronchogenic carcinoma on a cough history include
Hemoptysis Weight loss Cachexia Abnormal imaging
110
3 types of medication that may induce cough
ACEi, BB, Amiodarone
111
Precipitating factors of GERD include
Diet, Caffeine, High fat diet, excessive EtoH, smoking, certain medications (ex. NSAIDs)
112
What are most probable pathogens in AECOPD?
H.flu, M. Cat, Strep Pneumo
113
Obesity in Men = WC > ___
102cm
114
Obesity in Women= WC >___
88cm
115
BMI Classification: - Underweight=___ - Normal=___ - Overweight=___ - Obesity I=____ - Obesity II=___ - Obesity III=___
- Underweight <18.5 - Normal 18.5-24.9 - Overweight 25-29.9 - Obesity I 30-34.9 - Obesity II 35-39.9 - Obesity III 40
116
Potential target organ damage associated with obesity inclues
1. CVD (HTN and CAD) 2. Cancer 3. T2DM 4. OA and back pain
117
What are the components of the adolescent history?
HEEADSSS ``` Home Eating/Exercise Education/Employment Activities Drugs Sexuality Suicide Safety ```
118
What are 11 things that we should question based on choosing wisely?
1. Don't order imaging for lower back pain w/o red flag sx. 2. Don't use abx for URTIs that are likely viral or self-limiting. 3. Don't order screening CXR or ECG for asymptomatic/low risk outpatients. 4. Don't screen with Pap if age <21 or >69. 5. Don't do annual screening blood tests unless indicated by risk profile. 6. Don't routinely measure VitD in low-risk adults 7. Don't routinely screen with mammo for average risk women age 40-49. 8. Don't do annual physical exams on asymptomatic adults with no sig. risk factors. 9. Don't order DEXA screening for OP on low risk patients. 10. Don't advise non-insulin requiring diabetics to do routine SMGB between office visits. 11. Don't order thyroid function tests in asymptomatic patients.
119
What are some discussion topics at a periodic health exam?
New concerns, chronic illness status/follow-up, Lifestyle (helmets, seatbelts, EtOH, Tobacco, Drugs, contraception), safety, screening, +/- ROS
120
Populations not to miss in cervical cancer screening include
Pregnant women, Women who have sex with women, subtotal hysterectomy with retained cervix, transgender individuals with cervices
121
What are the recommendations for cervical cancer screening?
Pap test (cytology) starting at age 25 for sexually active women. Repeat every 3 years if screens negative. Stop at age 70 if the last three consecutive tests w/i the past 10 years have been negative.
122
When should a patient being screened with Paps be referred to colpo?
If cytology shows HSIL, ASC-H, AGC, AIS
123
What is the next step for a patient who screens positive for LSIL or ASCUS on cytology?
1) Repeat cytology in 6 mo. If normal, Repeat again in 6 mo. If normal again, return to q3years. 2) Repeat cytology in 6mo. If abnormal, send for colpo. 3) Repeat cytology in 6 months. If normal, repeat in 6 mo. If abnormal, send to colpo.
124
What are the high risk criteria for breast cancer?
Personal Hx BC, 1st degree relative with hx BC, known BRCA1/BRCA2 mutation, history of chest wall radiation
125
What are the screening recommendations for breast cancer?
Avg Risk Age 50-74: Screen with mammography every 2-3 years. High Risk Age 30-69 : Screen with mammography and breast MRI every year
126
What are the high risk criteria for colorectal cancer?
Personal Hx CRC or adenomatous polyps, 1st degree relative with hx CRC, IBD, Adults with hereditary syndromes predisposing to CRC (FAP or HNPCC)
127
What are the screening recommendations for colorectal cancer?
Avg Risk Age 50-74: FIT every two years (consider flex sig/colonoscopy every 10) High Risk: Screen with colonoscopy at Age 50 or 10 years before the dx of the relative. If family member dx before Age 60, screen every 5 years. If family member dx after age 60, screen every 10 yrs
128
List some risk factors that would lead one to screen for osteoporosis in a pt age <50?
Fragility fractures, Use of high risk meds, Hypogonadism, Malabsorption syndromes, Chronic Inflammatory conditions, Primary hyperparathyroidism, Other disorders strongly associated with rapid bone loss or fractures
129
List some clinical risk factors for osteoporosis?
Fragility fracture after Age 40, Prolonged use of glucocorticoids or other high-risk meds, Parental hip fracture/vertebral fracture/osteopenia, High EtOH intake or current smoking, low body weight or major weight loss, other disorders strongly associated with OP
130
When and how should screening be initiated for osteoporosis?
Screen with BMD and Risk Calculator. Age <50 if high risk factors Age 50-64 if clinical risk factors Age 65 and greater--everyone
131
How often should BMD be repeated for OP screening?
Low risk--every 5 years | Med/Mod risk--every 1-3 yrs
132
Who should be assessed annually for T2DM (Risk Factors)?
Family Hx (1st degree relative), High Risk Populations (non-white, low SES), Hx of GDM or pre-DM, CV risks, End-organ damage (vascular)
133
How often should we screen for T2DM and which tests are used?
FPG and HbA1C No RFs Age <40 (or low-mod risk): No screening No RFs Age >=40 (or high risk): q3 years RFs (or very high risk): q6-12 mo
134
Diagnostic Criteria for T2DM
FPG or A1C abnormal > Repeat same test to confirm dx Both FPG and A1C abnormal > dx confirmed Symptomatic Hyperglycemia > Only one abnormal test required (FPG, A1C, 2hPG, random PG)
135
A1C 6-6.4 % = ____
Prediabetes
136
A1C >= 6.5%= ____
Diabetes
137
FPG >= 7mmol/L= _____
Diabetes
138
Hyperlipidemia is screened with______
Non-fasting lipids and Framingham Risk Score | unless Hx of TG >4.5, then fasting lipids
139
What ages/how often should we screen for dyslipidemia?
Age 40 to 75, screen every 5 years | if no RFs
140
Risk factors for dyslipidemia that would prompt earlier screening include
Ethnic Groups (South Asian or First Nations), Smoking, DM, HTN, COPD, CKD, ED, Atherosclerosis, AAA, Inflammatory disease (RA, SLE, psoriatic arthritis, ankylosing spondylitis, IBD), BMI >27 or clinical manifestations of hyperlipidemia, FamHx of premature CVD or hyeperlipidemia
141
What ages/how often should we calculate CV risk?
Men Age 40-75 Women Age 50-75 Framingham Risk score every 5 yrs (if risk <5%) or every year i(if risk >=5%)
142
Ca Intake Recommendations
Age <50 1000mg Age >50 1200mg Post Menopausal 1500mg
143
Vit D Intake Recommendations
Low Risk 400-1000IU | High risk, >=50 yrs 800-1000IU, increased to 2000IU
144
Contraindications to Live Vaccinations
Pregnant women, Trying to conceive within next month, Already received a live vaccine in last 28 days, Immunocompromised or untreated TB, Received blood product in last 90 days
145
Who should receive HPV vaccinations?
Women age 9-45 | Men age 9-26
146
Age for Shingles Vaccine
Product monograph states 50+, NACI states 60+
147
Age/Population for Pneumococcal Vaccinations
Age 65+ | DM, CHF, COPD, CKD, Asplenia, Immunosuppresed, Liver disease
148
Adacel indications, frequency, age
Protects against Tetanus, Diptheria and Whopping Cough One lifetime dose Adolescents age 14-16 or adults who missed adolescent dose
149
Side effects of MMR
Rash 5-12 days after vaccine, fever in first 24 hrs or 5-12 days, Swelling of glands in neck, Temporary joint pain/muscle aches, meningitis (very rare), temporary thrombocytopenia
150
Which vaccination should be given in every pregnancy?
Pertussis
151
What is the recommendation around screening for prostate cancer?
Screening – men with at least 10 years life expectancy between 50 and 70 should be made aware of the availability of PSA as a detection test for prostate cancer • Offer at age 40 if high risk – family history and African descent • If the patient chooses screening: o Include PSA and DRE o Baseline PSA at age 40–49 years should be done to establish future risk By Age Group • Men < 55 – do not screen with PSA (strong recommendation) • Men 55 – 69 – do not screen with PSA (weak recommendation) • Men 70+ – do not screen with PSA (strong recommendation) Take away: lack of convincing evidence that PSA screening reduces mortality and consistent evidence that screening and active treatment does lead to harm (only test PSA in patients that are symptomatic)
152
Global Health – health problems, issues, and concerns that transcend _____ ______, and may be influenced by encounters or experiences in other countries, and are best addressed by ______ efforts and solutions
Global Health – health problems, issues, and concerns that transcend national boundaries, and may be influenced by encounters or experiences in other countries, and are best addressed by cooperative efforts and solutions
153
Menopause is defined as
12 months of amenorrhea with no other obvious pathological or physiological cause (retrospective diagnosis)
154
Contributing factors to age of menopause onset include
Genetics, Smoking, Pelvic Radiation, Chemotherapy
155
Premature Menopause = age___
<40
156
What labs could be considered in a workup of amenorrhea, particularly if age <45
BHCG, TSH, PRL, Progestin Challenge, FSH/LH, Primary Ovarian Failure
157
Clinical features of menopause
o Irregular/ anovulatory bleeding in perimenopausal period, amenorrhea in menopause o Vasomotor symptoms (hot flashes) o Urogenital changes o Sleep disturbances and mood changes/depression
158
Menopausal vaginal atrophy manifests as
Veginal dryness, dyspareunia, pruritis, frequent UTIs, prolapse, post-coital bleeding
159
Treatment for mild vasomotor symptoms of menopause includes
Reducing core body temperature (layering, use of a fan, drinking cold beverages), regular exercise, weight management, smoking cessation, controlled breathing, avoidance of triggers, good sleep
160
_____ is first-line treatment for mod-sev vasomotor symptoms of menopause.
HRT is first-line treatment for mod-sev vasomotor symptoms of menopause.
161
___, ___, ___, ___ are second-line treatment for mod-sev vasomotor symptoms of menopause.
SNRI, SSRI, Gabapentin, Progestin are second-line treatment for mod-sev vasomotor symptoms of menopause.
162
Two non-hormonal treatments for vaginal atrophy
Vaginal lubricants and Vaginal moisurizer
163
3 local estrogen therapy treatment options for vaginal atrophy
Estrogen cream (ex. Premarin; *requires co-tx with progestin for 10 days per month due to systemic absorption Estradiol Vaginal Ring Estradiol Vaginal Tablets (ex. Vagifem)
164
Stress incontinence tx
Weight loss, pelvic floor exercises, pessaries
165
Urge incontinence tx
Lifestyle changes, bladder retraining, antimuscarinic agents (oxybutynin)
166
For all menopausal women, osteoporosis prevention involves
Vit D supplementation (400-1000IU for low risk, 800-1000IU for mod risk) Ca intake (1200mg) Lifestyle (regular active weight bearing aerobic exercises, balance exercises, smoking cessation, decrease coffee and alcohol intake)
167
Indications for MHRT
Best tx for vasomotor sx, not recommended for osle tx of hyperlipidemia, CVD, OP *Remember to add progesterone if pt has a uterus
168
Contraindications to MHRT
Hx breast/uterine cancer, liver disease, DVT/PE hx, abnormal vaginal bleeding NYD, pregnancy, CAD
169
CAD risks/benefits of MHT
Coronary Artery Disease o There is a DECREASED risk of CAD with HRT use within 10 years of menopause o There is an INCREASED risk when HRT is started >10 years after the onset of menopause (In general Cardiovascular risk is highest in first 2 years of starting HRT, then excess risk decreases over time)
170
Risks of MHT include
-Increased risk of VTE with oral HRT -unopposed ET (with NO progesterone) > 3 years is associated with increased risk of endometrial cancer -diagnosis of breast cancer increases with EPT use GREATER than 3 – 5 years; N.B. data also indicates that ET use in breast cancer survivors has not been proven to be safe and is associate with recurrence -meta-analysis shows INCREASE in annual ovarian cancer risk for EPT and ET use
171
Components of Framingham Risk Score
``` Age Sex Smoking DM Total Chol HDL Chol SBP Blood Pressure treated by Meds ```
172
In general, lipid targets are:
LDL-C <2 or >50% decrease | Apo B <0.8, Non-HDL-C <2.6
173
Based on CCS Guidelines at what age should routine screening for hyperlipidemia be initiated and how frequently
• Men and women ≥40 years of age, or post-menopausal women • Consider earlier routine screening in ethnic groups at increased risk (South Asian or First Nations) • Screening Timeline o FRS<5%–patientsshouldbescreenedevery5years(from40to75) o FRS>5%–patientsshouldbescreenedyearly
174
Based on CCS Guidelines all patients with the following conditions should be assessed for hyperlipidemia regardless of age
``` • Clinical evidence of atherosclerosis • Diabetes mellitus • Hypertension or PIH • Abdominal aortic aneurysm • Current cigarette smoking • Stigmata of dyslipidemia (acrus cornealis, xanthelasma, or xanthoma) • COPD • Family history of premature CVD (men < 55 and women < 65 in first degree relative) • Family history of dyslipidemia • CKD(eGFR<60orACR>3) • Obesity (BMI ≥ 30) • Inflammatory disease • HIV Infection • Pregnancy-induced hypertension ```
175
Based on CCS Guidelines, how do we screen for hyperlipidemia
H&P, Standard lipid panel (TC, LDL-C, HDL-C, TG), Non-HDL-C (calculated from profile), Glucose, eGFR (Optional: Apo B, Urine ACR (if eGFR <60, HTN or DM) Lipids can be done non-fasting unless hx of TG>4.5
176
When to consider secondary hyperlipidemia testing with coronary artery calcium measurement
• May be appropriate for asymptomatic and middle-aged adults with a FRS 10 – 20%, or with a family history of premature CVD, for whom treatment decisions are uncertain • Do NOT do CAC screening in: o High-risk individuals o Patients receiving statin therapy o Most asymptomatic, low-risk adults
177
Based on Simplified Lipid Guidelines, screening ages and frequency of screening are
Lipid testing in patients without CVD: - Men–Age≥40 years to 75 - Women – Age ≥ 50 years to 75 (*NOTE----- CCS suggests age 40 for women Consider initiating testing earlier if CVD risk factors -Hypertension - Family history of premature CVD § Diabetes - Smoking • Repeat Screening o Patients NOT using lipid-lowering therapy→ every 5 years o Global CVD risk estimation can be repeated sooner if other CVD risk factors develop
178
Based on Simplified Lipid Guidelines how do we screen
Lipid testing + CVD risk assessment CVD risk calculator (i.e. FRS) should be used o Diabetes–same risk estimation as non-diabetic patients o Chronic Kidney Disease–use a CKD specific CVD risk estimator (QRISK2) • Do NOT perform risk assessments in: o Pre-existing CVD (already high risk) o Age <40 or Age>75 o Already on lipid therapy
179
CCS Guideline statin indicated conditions include
- LDL-C 5 or greater (genetic dyslipidemia) - Clinical Atherosclerosis - AAA - DM - CKD
180
CCS guidelines for primary prevention management of hyperlipidemia based on FRS
Low Risk FRS <10% => No pharm indicated; Health Behavioural Modifications (Smoking cessation, improved diet, exercise) ``` Intermediate Risk– FRS 10 – 19%, AND • LDL-C ≥ 3.5 mmol/L, or • Non-HDL-C ≥ 4.3 mmol/L, or • Apo B ≥ 1.2g/L Men ≥ 50 and Women ≥ 60 with a risk factor: • Low HDL-C • Impaired fasting glucose • High waist circumference • Smoker • Hypertension or High Risk (FRS 20% or greater) => Health behavioural modifications Statin therapy for those with LDL-C ≥ 3.5 (aiming for LDL-C < 2.0, or 50% reduction) Add-On Therapy If target not achieved after titrating statin up to the maximal dose tolerated: • Ezetimibe is first-line (Bile acid sequestrants as alternative) ```
181
Statin mechanism of action
Selective inhibition of cholesterol reabsorption at the | brush border of enterocytes (↓ LDL, minimal ↑ on HDL and minimal ↓ on TG)
182
Simplified Lipid Guidelines for hyperlimidemia
Lifestyle Interventions – should be discussed with all patients • Smoking cessation • Exercise • Mediterranean diet FRS <10%: Retesting lipid levels in 5 years with risk estimation Statin therapy is NOT indicated FRS 10-19%: Discuss initiation of moderate-intensity statins FRS 20% or higher: Strongly encouraged to discuss initiation of high-intensity statins Consider ASA
183
Statin Side Effects
* Muscle and liver injury * Elevation of blood glucose levels * Myalgias – common adverse effect * Rhabdomyolysis and liver failure – rare adverse effects (Patients who do not tolerate a specific statin regimen should be offered a lower-intensity regimen, with either the same or a different statin, or a short drug holiday followed by a rechallenge, to help clarify if statins are related • Any statin intensity is preferred to non-statin lipid-lowering therapy • Alternate daily dosing can be considered if a patient does not tolerate daily dosing)
184
What lab follow up is recommended by the CCS Guidelines for patients on lipid-lowering medications
* Serum transaminases (ALT/AST) should be checked within the first three months * Creatinine kinase (CK) can be checked in myalgias develop * Routine testing of ALT or CK is not required thereafter – NO routine follow-up of investigations
185
What lab follow up is recommended based on Simplified Lipid Guidelines?
• Testing of CK and ALT/AST levels at baseline or for monitoring are not required; performed only when clinically needed (symptoms) • Encourage adherence to statins • Monitoring of lipid levels are NOT required
186
Risk factors for T2DM
* Family history (first degree relative) * High risk populations (non-white, low SES) * History of GDM or pre-diabetes * Cardiovascular risk factors * Presence of end-organ damage (vascular) * Other conditions/medications associated
187
How to screen for T2DM
Screen with (1) FPG and (2) HbA1C • Asymptomatic Patient → if either FPG or A1C are in the diabetic range, repeat the SAME test that was abnormal to confirm the diagnosis of diabetes • Both FPG and A1C are available: o If only one is in the diabetes range, repeat the SAME test that was abnormal to confirm o If both tests are in the diabetes range, the diagnosis is confirmed • Symptomatic Hyperglycemic Patient → one only abnormal test (A1C, FPG, 2hPG, random PG) required Ultimately, two positive results are required unless there are overt symptoms of hyperglycemia
188
Who should be screened for T2DM
No RFs: Age 40+ or high risk should be screened every 3 yrs RFs: Screen q6-12mo
189
Recommended targets in T2DM patients
HbA1C 7% or less BP <130/80 LDL-C <2 (or 50% reduction from baseline)
190
Components of lifestyle management for diabetes care
Exercise, Diet, Smoking Cessation, Self-Management
191
First line agent for T2DM
Metformin
192
How often to adjust meds in T2DM tx to attain A1C goal
3-6 mo
193
If A1C <1.5% above target
Start/increase metformin if not at target within 3 mo
194
If A1C 1.5% or higher above targer
Start metformin immediately, consider second concurrent antihyperglycemic agent
195
If symptomatic hyperglycemia and/or metabolic decompensation
Initiate insulin +/- metformin
196
Info/SEs about GLP1ra
``` • Requires subcutaneous injection • GI side-effects • Gallstone disease • Contraindicated with history of medullary thyroid cancer or MEN2 ***Weight Loss*** ```
197
Info/SEs about SGLT2i
• Genital infections and UTI • Hypotension • Rare euglycemic DKA ***Weight Loss***
198
Antihyperglycemic agents that cause weight gain
Insulin, Thiazolidinediones (-glitazones), Meglitinide, Sulfonylurea (-9des)
199
Drugs for CVD risk reduction in patients with T2DM and poor glycemic control and CVD:
Statin + ACEi/ARB + ASA + Liraglutide (GLP-1 agonist), Empaglifozin/Canagliflozein (SGLT2 inhibitor)
200
Drugs for CVD risk reduction in patients with T2DM and: good glycemic control and CVD
Statin + ACEi/ARB + ASA
201
Drugs for CVD risk reduction in patients with T2DM and: 1)NO CVD but microvascular disease OR 2) Age 55 or older with additional CV risk factors
Statin + ACEi/ARB | ex. Ramipril 10mg PO daily
202
Drugs for CVD risk reduction in patients with T2DM and: age 40 or older / 30 or older with diabetes >15 yrs / lipid indications
Statin
203
What and how often should screening be done in T2DM
q3 to 6 Months – HbA1C/FPG, BP, BMI ``` Yearly – lipids (LDL, HDL, cholesterol, TG), retina exam, foot exam (monofilament), kidney exam (eGFR/ACR) ``` q3 to 5 Years – ECG
204
Type of neuropathy in T2DM
Distal symmetric polyneuropathy
205
Treatment of T2DM neuropathy
TCAs, gabapentin, tramadol Daily foot exams, comfortable/cushioned shoes, smoking cessation
206
First sign of glomerular damage in diabetic nephropathy
Microalbuminuria
207
Treatment of diabetic nephropathy
ACEi
208
Treatment of diabetic retinopathy
Retinal photocoagulation
209
Early sign of CVD in men is ___
Erectile Dysfunction
210
____ in normotensive patients with T2DM helps prevent macrovascular disease
ACEi
211
Questions to ask for hx of a red eye
* Visual acuity or vision changes * Physical pattern of redness (conjunctival, subconjunctival, episcleral/scleral, ciliary flush) * Pain and photophobia * Discharge, foreign bodies, abrasions * Changes in extraocular muscle use or structures
212
Ddx of Red Eye
- Dry eye disease - Blepharitis - Uveitis - Angle closure glaucoma - Carotid cavernous fistula - Endopthalmitis - Cellulitis - Anterior segment tumors - Scleritis - Subconjunctival hemorrhage
213
Urgent referral indicated if red eye and:
* Vision loss * Moderate to severe pain * Severe purulent discharge * Corneal involvement * Conjunctival scarring * Lack of response to therapy * Recurrent episodes of conjunctivitis * History of HSV eye disease
214
When to refer to optho for suspected acute conjunctivitis:
- Pain - Photophobia - Constant blurred vision - Hyperpurulent (gonococcal) - None of pain + photophobia + blurred vision + discharge + itching
215
Management of viral conjunctivitis
Very contagious No tx--sx management (cold compress, artificial tears, antihistamines) Refer to optho if sx do not resolve in 7-10 days
216
Management of bacterial conjunctivitis
Most are self-limiting in 1-2 wks therefore observation is reasonable in most cases Topical antibiotics reduce disease duration Avoid topical steroids • Antibiotics are recommended for: o Purulent or mucopurulent conjunctivitis o Patients with distinct discomfort o Contact lens wearers o Immunocompromised patients o Suspected chlamydial or gonococcal infections
217
Management of allergic conjunctivitis
* Avoidance of offending antigen * Use of saline solution or artificial tears * Use of topical antihistamines, decongestants, and mast cell stabilizers * NSAIDs and corticosteroids may be indicated in some cases
218
Primary causes of hypothyroidism
- Hashimoto's Thyroiditis (chronic autoimmune thyroiditis) - Transient hypothyroidism (ex. postpartum, painless thyroiditis) - Infiltrative (ex. sarcoid) - Meds - Iatrogenic (ex. RAI, thyroidectomy)
219
Secondary causes of hypothyroidism
- Pituitary lesion (TSH deficiency) | - Hypothalamic lesion (TRH def.)
220
Primary causes of hyperthyroidism
- Autoimmune Hyperthyroidism (Grave's, Rare-Hashitoxicosis) - Toxic Multinodular Goitre - Toxic Adenoma - Exogenous Thyroid - Postpartum Thyroiditis - Drug induced (amiodarone) - Neoplastic (RARE--Metastatic Thyroid Cancer)
221
Secondary causes of hyperthyroidism
TSH-producing pituitary adenoma
222
Pregnancy-related causes of hyperthyroidism
Gestational hyperthyroidism (seen with hyperemesis gravidarum) Trophoblastic disease
223
Risk factors for thyroid disease
* Personal history of autoimmune disease (Type I Diabetes) * Family history of thyroid disease * Personal history of neck irradiation * Drug therapy (amiodarone, lithium) * Women > 50 years of age * Postpartum, up to 6 months
224
Clinical features of hypothyroidism include
Bradycardia, diastolic hypertension, Cognitive impairment, depression, hair loss, dry skin, menstrual irregularities (menorrhagia), constipation, weight gain, lethargy, goitre, cold intolerance
225
Clinical features of hyperthyroidism include
Palpitations, tachycardia, atrial fibrillation, widened pulse pressure, hypertension, nervousness, tremor, anxiety, proximal muscle weakness, hair loss, menstrual irregularities (amenorrhea, oligomenorrhea), weight loss, goitre, heat intolerance, diaphoresis, clammy hands
226
Only initial test required to screen for thyroid disease is
TSH
227
When to order fT3 and fT4
If suspected hyperthyroidism to confirm thyrotoxicosis (increased fT3, normal fT4) May be measured to rule out TSH-producing pituitary adenoma (increased TSH, fT3 and fT4)
228
Primary care management of hypothyroidism involves
Treatment with levothyroxine, usually start at 50mcg daily (25 in kids and elderly), check TSH 6 weeks after initiation/dose change, and annually once normalized
229
List 5 treatment options for hyperthyroidism
1. Propylthiouracil (PTU) 2. Methimazole 3. RAI 4. Thyroidectomy 5. Beta-blocker (short-term tx of sx until above tx takes effect)
230
Subclinical hypothyroid: ____ TSH, ____ fT4 Subclinical hyperthyroid: ____ TSH, ____ fT4
Subclinical hypothyroid: increased TSH, normal fT4 Subclinical hyperthyroid: decreased TSH, normal fT4 Monitor TSH q 12 mo for hypo, q6-12mo for hyper
231
Maternal hypothyroidism is associated with _____ in newborns
Maternal hypothyroidism is associated with decreased IQ in newborns
232
Factors associated with increasing number and size of thyroid nodules
Grave’s Disease Pregnancy Low iodine intake → specifically, hyperfunctioning nodules (toxic adenomas)
233
Factors associated with increased risk of thyroid cancer
Hx of radiation to head or neck, younger than 20 or older than 70, Grave's, familyhx, MEN 2A and 2B
234
Approach to a thyroid nodule
• Serum TSH level should be measured during the initial evaluation of a patient with a thyroid nodule (such that those with low TSH should have → radionuclide scintigraphy performed to assess for “hot nodules”) • Thyroid U/S should be performed in patients with known or suspected thyroid nodule • FNA is the biopsy of choice for sampling thyroid nodules (except hyperfunctioning nodules, which do not require a biopsy) → only biopsy those > 1cm (or any with risk factors; extracapsular invasion, cervical LNs)
235
GAD= exessive anxiety and worry lasting min. 6 months, difficult to control worry, associated with three or more of what 6 criteria
BESKIM Blank mind Easily fatigued Sleep Changes Keyed up (restless) Irritability Muscle tension
236
Validated tool for screening of GAD in primary care
GAD-7 Scale
237
Investigations that can be ordered for anxiety disorders
Basic labs (CBC, lipids, lytes, fasting glucose, TSH, liver enzymes) Serum/urine tox screen (?substance use) ECG (for panic attacks)
238
Modifiable biological risk factors for anxiety
Various Medical Conditions • Endocrine – hyperthyroidism, hypoglycemia • Cardiovascular – angina, arrhythmia, CHF, pulmonary embolism, anemia • Respiratory – asthma, COPD, pneumonia • CNS – temporal lobe epilepsy, migraines, neoplasms Medication/Substance Induced • Stimulants (caffeine, beta-agonists) • Depressants (withdrawal from antidepressants, alcohol, benzodiazepines)
239
Non-modifiable biological risk factors for anxiety
Non-Modifiable
240
Non-modifiable psych risk factors for anxiety
Adverse Childhood Experiences – childhood trauma (abuse and neglect) and institutionalization Parental Factors – overprotectiveness, role modelling, early parental loss Social Factors – females have greater exposure to more stress events epidemiologically
241
How many social situations must invoke fear/anxiety in a diagnosis of SAD
2
242
In general what meds/substances can induce anxiety symptoms?
* Stimulants (caffeine, beta-agonists) * Sympathomimetic agents * Withdrawal from Depressants (anti-depressants, alcohol, benzodiazepine)
243
Treatment options for GAD
- CBT - Exercise, yoga, MBSR - SSRIs/SNRIs, Buspirone, Pregabalin are 1st line - TCAs, low dose BZDs to abort initial panic attacks but avoid prn short-acting BZDs
244
Treatment options for PD
- CBT - SSRIs/SNRIs - BZDs - TCAs and less commonly MAOIs can also be used
245
Treatment options for social anxiety disorder
- CBT - SSRIs/SNRIs - BZDs and BBs for acute situations and performance anxiety - TCAs and moclobemide can be used third line
246
Treatment options for OCD
- ERP - High dose often required of SSRIs/SNRIs or TAs (1st line: sertraline, paroxetine, fluoxetine, fluvoxamine) (2nd line: venlafaxine, clomipramine, mirtazapine, citalopram)
247
Treatment options for PTSD
- CBT or ERP - SSRIs/SNRIs (most evidence for sertraline) - Some evidence that antipsychotics may have a role in augmentation therapy
248
3 main types of symptoms in PTSD, duration >1 mo
1. Re-living (recurrent and intrusive memories/distress) 2. Avoidance 3. Arousal
249
Ddx for anxiety symptoms or organic medical disorders that may present with anxiety
• Cardiac – CAD, CHF, arrhythmia • Pulmonary – PE, asthma, COPD, upper airway obstruction, pneumonia • Endocrine – hyper/hypothyroidism, hyperparathyroidism, hypoglycemia, pheochromocytoma, menopause • Neurologic – neoplasm, encephalitis, vestibular dysfunction • Drugs – caffeine, amphetamines, cocaine, alcohol, nicotine, benzodiazepine withdrawal, decongestants, salbutamol, antipsychotic, levodopa, SSRIs • Psychiatric – phobias, other co-morbid psychiatric conditions (depression)
250
Principles for initiating pharm management of anxiety disorders
Adequate trial of 8–12 weeks at optimal dosage is needed to see a response from therapy § If inadequate response, switch to another agent § If a partial response achieved, consider adding an augmenting agent § Refer to a specialist or consider second/third line agents if still inadequate response
251
5 or more of the following symptoms required for MDD diagnosis
MSIGECAPS Mood decreased Sleep (increased/decreased) Interest (anhedonia) Guilt or worthlessness Energy decreased Concentration decreased Appetite (increased/decreased) Psychomotor slowing/agitation Suicidal ideation
252
Symptoms of depression can be classified into three groups
1. Affective 2. Cognitive 3. Neurovegetative
253
Components of the mental status exam
ASEPTIC A- Appearance, Attitude, Arousal, Activity S-Speech E-Emotion (Mood/affect) P-Perception (hallucinations, illusions, dissociative symptoms) T- Thought Process and Content I- Insight and Judgement C-Cognition
254
Most important risk factor for suicide
Previous attempts at suicide
255
Suicide RFs
SADPERSONS Sex (male), Age (elderly), Depression, Previous attempts, Ethanol use, Rational thinking loss, Social support lacking, Organized suicide plan, No spouse (for males), Sickness (chronic/severe)
256
Suicide PFs
Children, responsibility, pregnancy, religious beliefs, life satisfaction, reality testing, positive coping skills, good social supports, self-efficacy, fear of act, social disapproval, support from healthcare team, identification of future goals
257
Suicide at-risk populations
Post-partum women, past history of depression/anxiety disorders/chronic pain, multiple somatic complaints, history of abuse, elderly with behavioural changes/dementia, substance use
258
Ddx for depressed mood, including causes of secondary depression
- Sadness - Schizoaffective Disorder - Substance induced depressive disorder - Depressive disorder due to another medical condition (some disorders mimic/exacerbate depression ex. anemia, while some disorders can produce depressive syndrome as a direct physiological consequence (ex. MI, HIV, stroke)
259
Ix for depression (to rule out other conditions in ddx)
- Take careful history (r/o sadness) - Serum/urine tox screen (substance induced depressive disorder) - CBC, TSH, B12, folate (medical conditions) - CT/MRI brain, EEG/EMG, cardiac or autoimmune work-up
260
Validated scales designed to assess baseline mood and track tx
PHQ-9 and Beck Depression Inventory
261
Pharm tx counselling for depression can include
• Take medication daily and regularly • Physical symptoms of depression (appetite, sleep, energy) should improve within 1-3 weeks • Cognitive/emotional symptoms of depression (anhedonia, guilt, hopelessness take approximately 6-8 weeks • Although patients may feel better after 6-8 weeks, they will need to continue for 6-12 months (first episode) and at least 2 years (third episode of depression) • Do not stop antidepressant treatment abruptly • Not all antidepressants work for all people, so follow-up with doctor in 1-3 weeks • Side effects are common, but usually temporary • If patients experience new or more intense feeling of suicide, they should go directly to the emergency room
262
With pharm tx for depression: -If no response in 1-3 weeks: _____ • Partial response in 3-4 weeks: _____ • If after optimizing dose, poor clinical effect, ____ and consider _____
-If no response in 1-3 weeks: antidepressant should be switched • Partial response in 3-4 weeks: optimize dose • If after optimizing dose, poor clinical effect, re-evaluate diagnosis and consider augmenting pharmacotherapy by adding second agent
263
Non-pharm tx for depression can include
CBT IPT PST
264
4 types of mandatory physician reporting
1. Child abuse--if reasonable grounds to suspect a child < age 16 is or may require protection 2. Elder Abuse--must report to the Refistrar of the Retirement Homes Regulatory Authority or LTC home director if reasponable grounds to suspect that a resident has suffered harm or is at rik 3. Impaired Driving Ability --report to MTO 4. Sexual Abuse of a Patient--when sexually abused of another profession
265
Low risk drinking guidelines
* No more than 2 standard drinks on any one day * Women – up to 9 standard drinks a week * Men – up to 14 standard drinks a week
266
Alcohol Dependence – meeting ≥ 1 DSM criteria for dependence in the last 12 months o If yes to ≥3, of the following questions/sx there is an element of dependence
``` § Tolerance § Withdrawal § Drinking limits § Failed to cut down § Time § Spending less time on other matters § Continued drinking despite problems ```
267
Medical red flags for alcohol use (trigger to screen for more)
MCV > 96 ↑ GGT, AST, ALT (> 2:1 ratio) GERD, HTN, DM, pancreatitis Chronic non-cancer pain Sexual dysfunction Falls
268
Mental red flags for alcohol use (trigger to screen for more)
Cognitive impairment or decline Mood, anxiety, or sleep disorder Significant behavioural or academic challenges
269
Psychosocial red flags for alcohol use (trigger to screen for more)
Unexplained times off work or loss of employment Frequent no shows Poor medication adherence Recent/recurrent trauma/abuse High risk behaviour (gambling, DUI, STIs)
270
Physical findings of alcohol use disorders
• Smell of alcohol • Withdrawal symptoms – vomiting, diaphoresis, agitation, headache, tremor, seizures, hallucinations • Delirium tremens (↑ HR, ↓ BP, ↑ temperature, delirium) • Stigmata of liver disease – ascites, jaundice, clubbing, spider nevi, palmar erythema, gynecomastia, testicular atrophy, Dupuytren contractures, hepatomegaly/shrunken liver, splenomegaly
271
What questions are involved in the CAGE screen for AUD | Note: can also use the AUDIT3
C-Have you ever felt the need to cut down on your drinking? A-Have people annoyed you by criticizing your drinking? G-Have you ever felt guilty about drinking? E-Have you ever felt you needed a drink first thing in the morning (eye-opener) to steady your nerves to get rid of a hangover?
272
At-risk drinking is defined as
≥ 4 drinks (women) or ≥ 5 drinks (men) on ≥ 1 day(s) in the past year
273
Alcohol Abuse – meeting ≥ 1 DSM criteria for substance-use disorder in the past 12 months If yes to 1 or more of these screens, consider abuse and assess for dependence: ____
§ Role failure (missed work or class?) § Risk bodily harm (drinking and driving?) § Legal issues (DUI, MVC) § Relationship trouble (people complain about your drinking)
274
4 Major Symptom Domains of Substance-Use Disorder
1. Impaired Control 2. Social Impairment 3. Risky use 4. Pharm Criteria Note: DSM criteria for disorder due to a substance, pt must display 2 of the 11 symptoms within a 12mo period (symptoms classified in the above 4 groups)
275
Pharm tx for alcohol dependence may involve
- Naltrexone (efficacy beyond 12 weeks not established) - Acamprosate (for maintenance of abstinence, tx x 1yr) - Disulfiram (can be used months-yrs, don't use if going alcohol use)
276
Pharm Tx for EtOH withdrawal may involve
- diazepam or lorazepam | - thiamine
277
Tobacco Cessation Treatment Options
- Lifestyle (15 min bursts of daily mod activity and baanced diet) - Behavioral (modify triggers) - NRT - Meds (Varenicline--target quite day 8, black box warning for pts with psych illness; Bupropion SR)
278
ADLS=
DEATH ``` Dressing Eating Ambulating Toileting Hygiene ```
279
iADLs=
SHAFT ``` Shopping Housekeeping Accounting Food prep Transportation ```
280
For frail older patients blood sugar
5
281
For older adults, HbA1c targets tend to be ____
7.1-8.5%
282
With glycemic control in older adults, _____ is a better predictor of outcomes than ___ or ____
With glycemic control in older adults, postprandial glucose is a better predictor of outcomes than A1c or preprandial glucose
283
If screening older adults for T2DM, look at both ____ and ___
FPG and HbA1C
284
Screening patients age ____for T2DM is unlikely to be beneficial
>80 yrs
285
Hypertension Goals: Pt with DM ____ Pt with CAD, no DM ____ Pt with no comorbidities ____ Frail older adult with HTN, with or w/o DM= _____
Pt with DM <130/80 Pr with CAD, no DM <120/80 Pt with no comorbidities <140/90 Frail older adult with HTN, with or w/o DM= individualized target
286
DDx for Orthostatic Hypotension ("4D-AID")
With compensatory tachycardia: 4D 1. Deconditioning 2. Dysfunctional Heart (low LVEF or aortic stenosis) 3. Dehydration (From disease, dialysis, drugs) 4. Drugs (antihtn, antianginals, antiparkinsonian, antidepressant, antipsychotic, anti-BPH) Without compensatory tachycardia: AID 1. Autonomic Dysfunction (DM, low B12, hypothyroid, ethanol abuse, parkinsonism amyloid) 2. Idiopathic (pure autonomic failure--deletion of NE from sympathetic nerve terminals) 3. Drugs (BBs)
287
Risks of statins in older adults include
- Myalgias - Cognitive function - Rhabdo and liver failure - Asymptomatic increases in CK and liver enzymes
288
Cation when using CV risk assessment tools, as ___ alone can place individuals in high-risk categories
Age
289
A _____ is diagnostic of osteoporosis
Fragility fracture (any fall from standing height or less)
290
Diagnosis OP via BMD: femoral neck BMD _____ below the young adult mean. (T score ____)
Femoral neck BMD 2.5 SDs or more below the young adult mean. (T score 2.5 or less)
291
Treatment of Osteoporosis in Older Adults • ______ * _____ * _____
Treatment of Osteoporosis in Older Adults • Lifestyle modifications o Regular exercise–balance, strength, exerciset raining o Limit alcohol intake o Vitamin D3 and dietary/supplemental calcium (1200mg) should always be considered * Bisphosphonates (alendronate, risedronate, zoledronic acid) can be used as first-line therapy in men for the prevention of a fracture * Denosumab is indicated for treatment of women and men at high risk of fracture
292
Bisphosphonate adverse effects include
GI upset, esophagitis, gastritis, bone/muscle/joint pain, osteonecrosis of the jaw (rare), atypical femur fractures (rare)
293
Contraindications to bisphospnonates include
Severe renal impairment (relative), hypocalcemia, can't sit up for 30 mins, caution if dysphagia, esophageal disease, gastritis, duodenitis, ulcers
294
Preferred hepes zoster vaccination is ____
Shingrix: recombinant subunit zoster vaccine | superior than Zostavax--live attenuated zoster vaccine
295
Vaccines in older adults (4):
1. Shingles--age >50 2. High dose trivalent influenza vaccine--age 65+ 3. Pneumococcal Vaccine (PCV 23 for all adults 65+, PCV 13 for immunocomprosed or on an individual basis) 4. Tetanus--Td every 10 yrs, Tdap once as an adult
296
General suggested ages to stop cancer screening in older adults:
1. Breast cancer: age 75 2. Cervical cancer: age 70 3. Colorectal cancer: age 75 4. Prostate cancer: not recommended at any age for screening
297
Sexual History 5Ps
Partners, Practices, Protection, Past History, Pregnancy Prevention
298
Absolute contraindications to combined OCP include
* Acute liver disease, liver malignancy * Uncontrolled hypertension * Migraines with neurologic symptoms (aura) * Diabetes with evidence of vascular damage * Suspected pregnancy * Undiagnosed vaginal bleeding * Personal history or strong family history of VTE * Estrogen-dependent malignancy * Smoker over age of 35
299
Relative contraindications to combined OCP (must monitor) include
• Controlled hypertension – BP must be monitored and stay stable • Migraines without neurologic symptoms – if increases in frequency or new onset neurological symptoms, stop the OCP • Breastfeeding–combined OCP safe for lactation; may decrease the milk supply • Anti-epileptics – higher risk of failure and break through bleeding due to accelerated estrogen metabolism by liver; may help control menstrual seizures • Hyperlipidemia – may increase risk of pancreatitis • Gallbladder disease – small increase risk in symptomatic gallstones • Inflammatoryboweldisease–slightriskofrelapse,inadequateabsorption • SLE – may be considered if no evidence of nephritis or APLA
300
Progestin in contraception works by ____, ____, _____ and ____
Thinning endometrium, thickening cervical mucous, preventing LH surge (ultimately suppressing ovulation), alters tubal transport
301
Estrogen in contraception works by ___ and ____.
FSH suppression (suppressing follicular development) and endometrial proliferation
302
SEs and complications of progestins in contraception include:
``` • Breakthrough bleeding • Premenstrual Symptoms – bloating, water retention, breast tenderness • Weight Gain – increased appetite, dose dependent and typically only seen in higher doses • Acne ```
303
SEs and complications of estrogens in contraception include:
``` • Breakthrough bleeding • Nausea • Breast tenderness • Thromboembolic disease (DVT/PE), MI, and stroke • Headaches – migraines • Liver metabolism – active liver disease ```
304
Non-contraceptive benefits of combined OCP
* Menorrhagia, anemia * Cycle regularity * Dysmenorrhea and endometriosis (progestin) * Ectopic risk * PID (progestin’s effect on mucous) * Acne and hirsutism – ↑ SHBG due to estrogen • Ovarian cancer - ↓ cell damage/turnover * Endometrial cancer (progestin) * Benign ovarian cysts * Benign breast disease
305
Per SOGC’s Canadian Contraception Consensus (2015), ____ are the most effective method of reversible contraception and should be considered for any woman of reproductive age
IUDs
306
IUD mechanism of action:
Inflammatory response in the uterus (hostile to egg implantation), minimal effect on ovulation
307
Options for starting OCP and implications for contraception
1st day start--no BUC required, may have more initial SEs Quick start--start whenever, need BUC for 1 week, less SEs Sunday Start--BUC for 1 week if >5 days since LMP
308
Missed OCP pill during 1st week means:
Take 1 pill ASAP and next pill at regular time (e.g. may be taking 2 pills in 1 day)à continue taking 1 pill daily until the end of the pack à use BUC for the next 7 days if missed pill à consider emergency contraception if unprotected intercourse in the last 5 days
309
Missed OCP pill during 2nd or 3rd week
Take 1 pill ASAP and next pill at regular timeàcontinue taking 1 pill daily until the end of the pack, discard any placebo pills, start a new cycle with no hormone free interval à if more than 3 pills missed, use BUC for 7 days à consider emergency contraception if UIC within last 5 days
310
Potential drug interactions with OCP include
``` Anticonvulsants Anti-TB Anti-fungal Anti-retroviral St. John's Wort ```
311
Emergency contraception options include:
- Insert Copper IUD up to 7 days after UIC - Oral progestin - Yuzpe Method (combined OCP with high dose progrestin, N/V is common SE and limits efficacy) - PLan B (progestin onlY)--OTC wihin 72 hrs after UIC (data showing can be effective up to 5 days post)
312
4 things to assess on first newborn visit to PCP
1. Dehydration 2. Jaundice 3. Feeding problems 4. Congenital anomalies
313
Earliest sign of dehydration in infants is ___
Abnormal vitals
314
Normal Growth • Weight loss nadir is usually around day ____; • No intervention is necessary unless the baby has lost ____ of their BW • Infants should return to birth weight by ___
* Weight loss nadir is usually around day 3 – 4; weight begins to increase once the mother’s milk comes in * No intervention is necessary unless the baby has lost more than 10% of their birth weight * Infants should return to birth weight by 2 weeks
315
Rule of 3s for colic (diagnosis of exclusion)
Crying >3hrs per day, episodes on more than 3 days per week, has lasted longer than 3 weeks
316
Localized reactions to immunizations include
* Swelling * Induration * Erythema * Tenderness * Localized Rash
317
Systemic reactions to immunizations include
* Fever • Rash * Joint/muscle pain * Fainting * Seizures * Guillain-Barré
318
Jaundice history can involve
- Bili levels at 24hrs - Birth history - FamHx of jaundice in siblings - Feeding Hx - Maternal blood type - Stool/urine output - Time frame
319
RFs for severe hyperbilirubinemia
* Cephalohematoma or significant bruising * East Asian * Exclusive breastfeeding if not well established * Weight loss over 10% (breastfeeding jaundice is due to dehydration) * Lower gestational age * Isoimmune or other hemolytic disease * Serum bilirubin levels pre-discharge in high/high-intermediate risk zone * Previous sibling with jaundice that received phototherapy * Jaundice observed in first 24 hours
320
+ Coombs test indicates___
Hemolysis
321
Jaundice in _____is always abnormal. Breastmilk/physiological jaundice usually occurs at ___ postnatal
Jaundice in the first 24 hrs of life is always abnormal. Breastmilk/physiological jaundice usually occurs at 2-3 days postnatal
322
Aside from structural causes, the two most common causes of murmurs are
Fever and Anemia | These are flow murmurs, best heard at LSB and radiate to the carotids
323
Describe a Still's Murmur
Innocent heart murmur commonly heard in children - Systolic ejection murmur - Low-pitched vibratory grade 2 murmur with a musical quality - Best heard at LLSB, thought to be due to vibration of the left outflow tract - No associated symptoms
324
On taking history for a heart murmur in a baby, ask about:
- Hx of congenital heart disease in 1st degree relatives - In utero drug exposure - Maternal DM - Intrauterine infections (rubella) - FamHx SCD
325
Physical exam for heart murmur in a baby
- General appearance - Vitals (BP in R arm, palpate brachial pulses, femorals one at a time, and R brachial simultaneously with femoral to assess for likelyhood of coarctation) - Precordial Exam - Signs of HF
326
Describe a Functional Murmur
Innocent murmur, position-dependent that disappears when upright or sitting
327
Systolic murmurs in babies include:
ASD, VSD, Blood flow across an outflow tract, AV valve regurg, PDA, functional (venous hum or still's)
328
Pathological murmurs in babies include:
PFO/ASD: Widely split fixed S2 and systolic ejection murmur at the LUSB VSD: Harsh holosystolic murmur at LLSB CoA: Systolic murmur heard loudest below L scapula
329
Characteristics more likely to be associated with innocent murmurs (7 S)
* Sensitive – changes with position or respiration * Short duration – not holosystolic * Single – no associated clicks or gallops * Small – limited to a small area, non-radiating * Soft – low amplitude * Sweet – not harsh sounding * Systolic – limited to systole
330
The ____ visit is considered to be the most important developmental assessment
18 month
331
Autism history may include:
* Take full developmental history of child * Family history of developmental delay * Parental concern of hearing and vision * History of repetitive, ritualized, or stereotyped behaviour such as hand flapping * Frequent tantrums or trouble tolerating change or transition * Preoccupation with parts of toys or different objects * RED FLAG – regression is never normal
332
DDx for ASD
* Anxiety disorder * Attachment disorder * Fetal alcohol syndrome * Global developmental delay * Hearing impairment * Language disorder * Learning disability
333
3 steps of the Gold Standards Framework-Proactive Identification Guidance (GSF PIG) in palliative care
Identify Assess Plan
334
Examples of general indicators of patient delcline
• General physical decline, increasing dependence and support • Repeated unplanned hospital admissions • Advanced disease (unstable, deteriorating, high burden) • Presence of significant multi-morbidities • Decreasing activity (limited self-care, in bed or chair 50% of the day and increasing dependence in most ADLs) • Decreasing response to treatments, decreasing reversibility • Patient choice for no further active treatment and rather a focus on their quality of life • Progressive weight loss (> 10%) in past six months • Sentinel event (fall, bereavement, transfer to nursing home) • Serum albumin < 25g/l
335
Two scoring scales used in palliative care
PPS (Palliative Performance Scale) -Uses ambulation, activity & evidence of disease, self-care, intake, LoC Edmonton Symptom Assessment Scale -Pain, tiredness, drowsiness, nausea, appetite, SOB, depression, anxiety, wellbeing
336
Components of the SPIKES approach
``` SPIKES Scene Perception Invitation Knowledge Empathy (NURSE: Name, Understand, Respect, Support, Explore) Summary ```
337
Pain relief at the end of life: Mild pain-- Mod pain-- Severe pain--
Mild pain--acetaminophen and/or NSAIDs (particularly in bone pain); avoid NSAIDs in elderly, renal impairment, GIB (consider PPI) Mod pain--weak opioid (codeine or tramadol) Severe pain--strong opioid (morphine, oxycodone, hydromorphone)
338
Opioid dosing
Codeine > Morphine > Oxycodone > Hydromorphone
339
Breakthough opioid dose is ___ of 24 hr total q1h prn
10%
340
Titrating Opioid Dose Upwards (to be done if ___ of breakthrough needed/24 hours) • Add up previous 24 hour total, and divide by ___ to get the new q4h dose • Give ___ of this NEW 24 hour total as the breakthrough dose
Titrating Opioid Dose Upwards (to be done if > 2 doses of breakthrough needed/24 hours) • Add up previous 24 hour total, and divide by 6 to get the new q4h dose • Give 10% of this NEW 24 hour total as the breakthrough dose
341
Opioid adverse effects include
* Constipation (prevent or treat with PEG 3350 or senna) * Somnolence/sedation (consider switching or adding a psycho-stimulant) * Nausea (metoclopramide 10mg PO/SC/IV QID prn) * Neurotoxicity (avoid renal impairment – good hydration) * Respiratory depression (RARE if carefully titrating)
342
Principles for managing dyspnea in palliative patients
* Awareness of breathing – frequent and often multifactorial * Treat/optimize treatment for reversible causes (PE, COPD) * Try air directed across the face, sit upright and by open window * Systemic opioids – initiate as for pain * O2 nasal prongs in hypoxic patients (SpO2 < 88% or PaO2 < 55mmHg)
343
Treatments of N/V in palliative patients: • Opioid Induced – ____ • Malignant Bowel Obstruction – ____ • Chemo/Radiation Induced – ____
* Opioid Induced – metoclopramide, haloperidol (1 – 5mg PO/SC BID/TID prn) * Malignant Bowel Obstruction – haloperidol * Chemo/Radiation Induced – ondansetron 4 – 8mg PO/SC/IV BID/TID
344
If suspicion of spinal cord compression in palliative pt treat with ___ while urgently referring for radiotherapy and/or neurosurg
Dexamethasone 8-10mg PO/SC/IV stat, then BID/TID
345
Folic Acid Supplementation: Low risk: Mod risk: High risk:
Low risk: 0.4mg PO daily Mod risk: 1mg PO daily until 12 weeks, then 0.4-1mg po daily High risk: 4mg PO daily until 12 weeks, then 0.4-1mg PO daily
346
Timing and frequency of antenatal visits
* 8 to 12 weeks GA – first visit * Until 28 weeks GA – every four weeks * From 28 to 36 weeks GA – every two weeks * From 36 weeks GA to delivery – every week
347
``` Summary of Ix throughout pregnancy: 8-12 wks= 11-14 wks= 18-20 wks= 24-28wks= 27-32wks= 28wks= 35-37wks= 41wks to delivery= ```
8-12 wks= 1st visit, labs, dating US 11-14 wks= eFTS, NT 18-20 wks= Anatomy Scan 24-28wks= GDM Screen 27-32wks= Pertussis Vaccine 28wks= Repeat CBC, RhIG if Rh- 35-37wks= GBS swab 41wks to delivery= BPP twice weekly until delivery
348
GDM screen is ___, can be escalated to ___ if abnormal
OCG (abnormal is 7.8-11, go on to OGTT, if >11.1 then dx GDM) OGTT (abnormal fasting 5.3 or higher, 1-hour 10.6 or higher, 2-hour 9.0 or higher; one abnormal value= GDM)
349
TORCH infections inlcude
``` Toxoplasmosis Other (parvovirus, varicella, syphilis) Rubella CMV HSV ```
350
Components of BPP
``` Fetal breathing Fetal movement Fetal tone Amniotic fluid (NST) ```
351
Management of NVP
- Dietary/Lifestyle Changes - Non-pharm (ginger tablets, MBCT) - Pharm (Vit B6, Doxylamine, Diclectin, Dimenhydrinate, Metaclopramide) - Refractory--consider hospitalization, ondansetron, corticosteroids, investigate for other causes
352
Recommended weight gain in pregnancy: BMI<20= BMI 20-27= BMI >27=
BMI<20= 28-40lbs BMI 20-27= 25-35lbs BMI >27=15-25lbs
353
Reasons to restrict intercourse during pregnancy may include
PPROM Threatened preterm labour Antepartum hemorrhage Placenta Previa
354
If pregnant woman is rubella non-immune____
Give MMR vaccine imeediately postpartum
355
Tdap vaccine generally given to pregnant women at____
27-32wks GA
356
Name 4 medications that are contraindicated in pregnancy
- ACEi (renal tubular agenesis) - Tetracycline (teeth/bone abnormalities) - Retinoids (CNS, craniofacial, CVS anomalies) - Diethylstillbesterol (Vaginal carcinoma, GU defects)
357
DDx for first trimester vaginal bleeding includes
- Normal early gestation - Ectopic pregnancy - Early pregnancy loss - Gestational trophoblastic disease
358
``` Threatened Abortion: Cervical Os __ Bleeding/Cramping__ Fetal Cardiac Activity__ Pregnancy Tissue Passed__ ```
Cervical Os Closed Bleeding/Cramping Yes Fetal Cardiac Activity Possibly Pregnancy Tissue Passed None
359
``` Incomplete Abortion: Cervical Os __ Bleeding/Cramping__ Fetal Cardiac Activity__ Pregnancy Tissue Passed__ ```
Cervical Os Open Bleeding/Cramping Yes Fetal Cardiac Activity No Pregnancy Tissue Passed Partially
360
``` Inevitable Abortion: Cervical Os __ Bleeding/Cramping__ Fetal Cardiac Activity__ Pregnancy Tissue Passed__ ```
Cervical Os Openning Bleeding/Cramping Yes Fetal Cardiac Activity No Pregnancy Tissue Passed Partially
361
``` Complete Abortion: Cervical Os __ Bleeding/Cramping__ Fetal Cardiac Activity__ Pregnancy Tissue Passed__ ```
Cervical Os Closed Bleeding/Cramping Yes Fetal Cardiac Activity No Pregnancy Tissue Passed Completely
362
``` Missed Abortion: Cervical Os __ Bleeding/Cramping__ Fetal Cardiac Activity__ Pregnancy Tissue Passed__ ```
Cervical Os Closed Bleeding/Cramping No Fetal Cardiac Activity No Pregnancy Tissue Passed None
363
-β-hCG should double every ____ for a normally developing pregnancy until it peaks at ~ 100 000 (at about 8 – 10 weeks gestation)
24 hrs
364
β-hCG that do not increase by at least ___in ____ is diagnostic of a non- viable pregnancy, but does not indicate pregnancy location
53% in 48hrs
365
Management options for a confirmed non-viable early IUP may include
1. Expectant management 2. Medical management with mifipristone+misoprostol 3. Surgical management with D&C
366
RFs for ectopic pregnany include
- Tubal damage or pelvic scar tissue - Contraceptive failure - Infertility - Maternal factors (ex. smoking, advanced maternal age)
367
ACS typically describes these three major cardiac conditions
1. Unstable Angina 2. NSTEMI 3. STEMI
368
Typical ACS presentation may involve
• Sub-sternal chest pain, right or left-sided • Characterized as squeezing, heavy, crushing, a fullness or pressure, radiating into jaws or arms • History of pain aggravated by exercise and relieved with rest or nitroglycerin • Symptoms can include nausea, dyspnea, diaphoresis, or syncope
369
Atypical presentation of ACS may involve
* No chest pain, point tenderness, or presents with chest pain characterized as stabbing/sharp * Can also be associated with symptoms of nausea, dyspnea, diaphoresis, or syncope * Symptoms may not have historical patterns or relief with nitroglycerin
370
Longterm management/secondary prevention in patient post-ischemia/infarction may include:
1. Anti-platelet and anti-coag therapy (ASA + Clopidorel/Ticagrelor +/- Anticoag 2. ACEi (or ARB) 3. BB (or CCB) 4. Statin (5. Nitrates for sx relief)
371
Strokes can be a) ___ or b) ___. a) can be ___ or ___ b) can be ___or ___
Strokes can be a) ischemic or b) hemorrhagic. a) can be embolic or thrombotic. b) can be intracerebral or subarachnoid.
372
DDx for CVA signs/symptoms includes:
Seizure, Somatoform/Conversion Disorder, Migraine, Toxic-Metabolic Disturbances, Systemic Infection, Syncope/Presyncope/Hypotension, Tumour, Acute Confusional State, Dementia, Dizziness/Vertigo, Spinal Epidural Hematoma (rare)
373
Initial work-up of a patient presenting with a CVA includes:
1. Urgen non-contrast CT head or brain MRI (mainly to r/o hemorrhagic stroke) 2. Lumbar puncture (if suspected subarachnoid hemorrhage and normal non-contrast CT head) 3. Blood glucose, lytes, renal function, lipid profile, CBC, CK, trop, INR/PTT 4. ECG
374
tPA is indicated within ___ of last seen normal
4.5 hrs
375
Long-term secondary prevention of stroke includes:
- Aggressive RF modification - BP management - Lipid Management (note: if recent ACS and established CAD, target LDL <1.8) - DM target AIC <7, FPG 4-7 - Smoking Cessation - Depression/ANxiety and Cognitive - Functional assessment post-stroke (ex. fatigue)
376
Immediate secondary prevention of stroke includes:
-Antiplatelet Therapy (ASA load followed by daily dose OR Clopidogrel load followed by daily dose) (Diff than MI/ACS where BOTH ASA and clopidogrel used) - Antithrombotic for Afib (DOAC for CHADS 2 or higher) (Note: use of both anticoag and antiplatelet should be avoided unless medically necessary) - Carotid Artery Evaluation (refer for patients with TIA or non-disabling stroke; mild stroke/TIA should be offered carotid endarterectomy w/i 14 days of stroke onset)
377
CHADS2-VASc Score
``` Congestive HF (1) HTN >140/90 (1) AGE >75 (2) DM (1) Prior TIA or stroke (2) Vascular disease (1) Age 65-72 (1) Sex Category (F=1) ```
378
RFs for cerebrovascular disease include
Non-Modifiable: age, famhx Chronic conditions: DM, CKD, sleep apnea, HTN, Afib Lifestyle factors: Smoking, poor diet, physical inactivity
379
3 symptoms seen in COPD
Dyspnea, Chronic Cough, Sputum
380
5 Key screening questions for COPD
1. Do you cough regularly? 2. Do you cough up phlegm regularly? 3. Do even simple chores make you short of breath? 4. Do you wheeze when you exert yourself, or at night? 5. Do you get frequent colds that last longer than other people? If the answer to any of these is YES – proceed to spirometry
381
Diagnosis of COPD requires lung function confirmation of _____ WITHOUT ____ • Reduced FEV1/FVC ratio (
Diagnosis of COPD requires lung function confirmation of airflow obstruction WITHOUT reversibility • Reduced FEV1/FVC ratio (<0.7) • High RV – due to gas trapping • HighTLC- due to hyperinflation
382
As COPD severity increases, FEV1 ____
Decreases
383
AECOPD characterized by increased ____, ____ and ____
Dyspnea, sputum volume, sputum purulence
384
Bugs typically implicated in simple AECOPD
H. influenza, M catarrhalis, S. Pneumoniae
385
Complicated AECOPD has increased sputum purulence and dyspnea as well as at least one of:
FEV1 <50%, 4_ exacerbations per year, Ischemic heart disease, use of home O2, chronic oral steroid use
386
Mainstay tx for mod-sev AECOPD is ___
Systemic steroids 50mg daily for 5-14 days
387
1st line abx in uncomplicated aecopd
Amoxicillin
388
1st line abx in complicated AECOPD
Fluroquinolones (cipro)
389
Symptomatic relief in AECOPD
SABA (ventolin/salbutamol) and SAAC (Atrovent/ipratropium)
390
Complications of AECOPD include
Ischemic heart disease, metabolic syndrome, Cor pulmonale, anemia, pulmonary HTN, lung cancer, cachexia, malnutrition, peripheral muscle dysfunction, osteopenia/osteoporosis, glaucoma, cataracts, anxiety, depression
391
Most effective intervention to decrease risk of COPD and slow progression is ___
Smoking Cessation
392
Examples of non-pharm interventions in COPD
exercise, pulmonary rehab, smoking cessation
393
Pharmacotherapy in COPD - 1st line mild COPD and available as PRN= _____ (____ex. salbutamol, or ____ ex. ipratropium bromide) - 1st line mod COPD or 2nd line mild COPD= ___ (___ ex. fomoterol, or ___ ex. tiotropium) - ___ should never be used alone in COPD, should be added to LABA for mod-sev COPD with 1 or more exacerbations per year
Pharmacotherapy in COPD - 1st line mild COPD and available as PRN= Short Acting Bronchodilators (SABA ex. salbutamol, or SAAC ex. ipratropium bromide) - 1st line mod COPD or 2nd line mild COPD= Long Acting Bronchodilators (LABA ex. fomoterol, or LAAC ex. tiotropium) - ICS should never be used alone in COPD, should be added to LABA for mod-sev COPD with 1 or more exacerbations per year
394
Add-on oral therapies in severe COPD include
Methylxanthines | Roflumilast
395
3 key findings to diagnose asthma in children
1. Documented airflow obstruction (ex. wheezing seen by HCP) 2. Documented reversibility of airflow obstruction (ex. response to SABA =/- steroid, improved wheezing) 3. No clinical evidence of alternative dx
396
Options for diagnosing asthma in individuals > age 6
**Preferred method: reversible airway obstruction on spirometry (12% or > increase in FEV1 after SABA or ICS course) Alt: PEF variability (ex. 20% or > improvement in PEF with SABA or ICS course) Alt: Positive challenge test (methacholine or exercise challenge-->10% drop in FEV1 following exercise
397
Paediatric Athma DDx
- Rhinosinusitis - Upper airway obstruction - Foreign body and aspiratory - Bronchiolitis - Phenumoina, Atelectasis, Tuberculosis, Pertussis - Bronchopulmonary Dysplasia - Congenital Pulmonary Artery Malformation, Bronchiectasis, CF - Primary Ciliary Dyskinesia - GERD - Eosinophilic Esophagitis, swallowing problem +/- aspiration - Immune disorder - Pulmonary edema secondary to myocarditis, pericarditis, congenital cardiac disease
398
Do not order ___ or ___ to confirm asthma, unless ruling out other causes
Full PFTs or CXR
399
In asthma, ICS work by decreasing _____ migration and reversing ____ permeability to prevent or control ____. Side effects include oral ___, dry ____, similar to _______ when used at high doses
In asthma, ICS work by decreasing neutrophil migration and reversing capillary permeability to prevent or control inflammation. Side effects include oral thrush, dry mouth, similar to systemic steroids when used at high doses
400
In asthma, SABA work by stimulating ____ receptors which lead to _____ relaxation and ____ stabilization. Side effects include ____, ____, _____, ____, ____.
In asthma, SABA work by stimulating beta-2 receptors which lead to smooth muscle relaxation and mast cell stabilization. Side effects include tachycardia, palpitations, anxiety, dry mouth, hypokalemia.
401
In asthma, LTRA work by decreasing _____, vascular _____, mucosal ____ and mucus ____. Side effects include abdo pain, dyspepsia, elevated ____, headache.
In asthma, LTRA work by decreasing LT-induced bronchospasms, vascular permeability, mucosal edema and mucus production. Side effects include abdo pain, dyspepsia, elevated liver enzymes, headache.
402
Examples of risks for asthma exacerbation
FEV1 <60%, ED/hospitalization in past year, CVD
403
Examples of aggravating comorbidities in asthma
Rhinitis, GERD, Obesity, Psychosocial issues, sleep apnea
404
In asthma, SABA should be used as ___
PRN for acute asthma attacks
405
In asthma, ICS is ___ for mild-to-severe asthma
mainstay therapy
406
in asthma, LABA (ex. formoterol) can be added to ___ rather than increasing ___
ICS, ICS
407
Asthma tx for kids < 6 years old: Mild: ___prn Mod-Sev: ___prn + low-dose ___ daily (increase to medium dose as required) NO ____ or ___ for young children
Mild: SABA prn Mod-Sev: SABA prn + low-dose ICS daily (increase to medium dose as required) NO LABA or LTRA for young children
408
Non-pharm asthma therapy includes
- Physical activity - Tobacco Cessation - Avoid aggravating medications - Avoid triggers (limited efficacy) - Influenza Vaccination
409
Summary of Pharmacological Therapy for Asthma • ____ prn – for everyone, as a reliever • ___ low-dose daily (at least) – for everyone, as first-line control • Further Management o If < age 6→ increase ___ dose o If > age 6 → add ___→ add ___
Summary of Pharmacological Therapy for Asthma • SABA prn – for everyone, as a reliever • ICS low-dose daily (at least) – for everyone, as first-line control • Further Management o If < age 6→ increase ICS dose o If > age 6 → add LABA → add LTRA
410
Managing acute asthma exacerbation: - proceed to ED - determine underlying cause - give oral ___ x 5 days (if initial SpO2 <96 in kids, <94 in adults) - give ___ if hypoxic - ___ (may need back-to-back) - consider ___ - consider ____
Managing acute asthma exacerbation: - proceed to ED - determine underlying cause - give oral prednisone x 5 days (if initial SpO2 <96 in kids, <94 in adults) - give if hypoxic - salbutamol (may need back-to-back) - consider ipratropium - consider MgSO4
411
``` Adequate Asthma Control: o Day time symptoms ____ per week o Night time symptoms___times per week o Normal exercise tolerance o Mild infrequent ____ only o No missed days of school/work due to asthma o ___ doses of SABA in a week ```
``` o Day time symptoms <4 days per week o Night time symptoms 0 times per week o Normal exercise tolerance o Mild infrequent exacerbations only o No missed days of school/work due to asthma o <4 doses of SABA in a week ```
412
NYHA Functional Classification - Class I: ___ - Class II: Symptoms with ____ - Class III: Symptoms with ____ - Class IV: Symptoms at ___
- Class I: Asymptomatic - Class II: Symptoms with ordinary activity - Class III: Symptoms with less than ordinary activity - Class IV: Symptoms at rest
413
Initial CHF workup may include:
-Labs: CBC, lytes, Cr, eGFR, U/A, ACR, albumin, AST, TSH, FBG, lipid profile, BNP, ECF, -CXR -Echo +/- more specialized testing
414
Normal LVEF ___ HFpEF ___ HFrEF (systolic HF) __
Normal LVEF >60% HFpEF >40% HFrEF (systolic HF) <40%
415
Non-pharm management of CHF involves
- Monitor daily weights - Dietary changes - Mod intensity aerobic and resistance exercise - Immunization
416
Pharm involved in tx of symptomatic HF
1. Diuretics 2. ACEi and BB (sub ARB if intolerant) - HFpEF: 1+ 2+ treat inderlying cause - HFrEF: 1 + 2+ below - NYHA II-III with persistent symptoms add ARB, consider dig +/- nitrates and specialist referral - NYHA III-IV with persistent symptoms increase or combine diuretics, add spironolactone, consider specialist referral
417
Osteoblasts are bone forming cells that respond to ___ and ___
PTH and Vit D
418
Osteoclasts are bone resorpting cells that respond to ____
RANK/RANKL
419
Osteopenia defined as T-score ___ to ___
-1 to -2.4
420
Osteoporosis defined as T-score < ___
-2.5
421
T-score compares BMD to ___
Young healthy adult reference population
422
Z-score compares BMD to ___
Individuals of the same age and sex
423
Fragility fracture is any fall from a standing height or less that results in fracture, except for ___
Hand, foot skull
424
Secondary causes of osteoporosis include
RA, T1DM, Hyperthyroidism, POI, Hypogonadism, Chronic Liver Disease
425
Relevant physical examinations for patients with low bone mass includes
- Weight (>10% loss since age 25 is significant) - Vertebral fracture screen (heigh annually, rib to pelvic distance, occiput to wall distance) - Assess falls-risk with get up and go test (>15s is increased risk)
426
Screening/Ix for low bone mass/OP includes
Ca, Vit, Alb, TSH, ALP, CBC, Cr/eGFR, SPEP if known vertebral fracture (re-check Vit day 3-4 mo after supplementation) BMD
427
Indications to order BMD include
- Men and women age >65 - menopausal women/men age 50-63 with # risk factors (ex. prolonged glucocorticoid use, parental hip fracture, RA) - adults <50 with (fragility #, prolonged glucocorticoids, other high-risk meds, hypogonadism or premature menopause, malabsorption syndrome, primary hyperpara, other disorders stronly associated)
428
Vit D supplementation 800-2000IU after age ___, 400-1000 for those ___
50; <50 at low risk
429
CAROC Guidlines: 10-yr fracture risk, based on femoral neck T-score and age - Low risk (<10%): __ - Mod risk: __ - High risk (>20%): __
- Low risk (<10%): no pharm - Mod risk: discuss risks/benefits - High risk (>20%): pharm
430
FRAX questionnaire more accurate when pt has more than one RF, includes demographic parameters such as
Age, Sex, Wt, Ht, Prev #, Current Smoking, Glucocorticoid use, RA, EtOH
431
1st line agent for tx of osteoporosis is:
Bisphosphonates (ex. Risendronate)
432
Contraindications to bisphosphonates include
Denosumab tx, pregnancy, CKD
433
SEs of oral bisphosphonates include
GI irritation, MSK, acute-phase reaction Rare risks: oseonecrosis of the jaw, atypical femur fractures with long term use
434
AOBP threshold for diagnosing HTN is SBP ___ or DBP ___
SBP ≥ 135mmHg or DBP ≥ 85mmHg
435
Non-AOBP threshold for diagnosing HTN SBP ___ or DBP ___is
SBP ≥ 145mmHg or DBP ≥ 90mmHg
436
Threshold for diagnosing HTN in DM is SBP ___ or DBP __; Other high risk patients/older patients___
SBP ≥ 130mmHg or DBP ≥ 80mmHg Other high risk patients/older patients SBP ≥ 130mmHg
437
HBPM threshold for diagnosing HTN is SBP ___ or DBP ___i
SBP ≥ 135mmHg or DBP ≥ 85mmHg
438
ABPM threshold for diagnosing HTN is
Mean 24-hour SBP ≥ 130mmHg and/or DBP ≥ 80mmHg Mean Daytime SBP ≥ 135mmHg and/or DBP ≥ 85mmHg
439
Target organ damage from HTN includes
-CVD, cerebrovascular disease, Hypertensive retinopathy, PAD, Renal disease
440
List secondary causes of HTN and a test that could be ordered for each
1. Hyperthyroidism > TSH 2. Renal disease > Renal US 3. Cushing's > 24 hr cortisol excretion 4. Primary hyperaldosteronism > aldosterone-renin ratio 5. Pheochromocytoms > Plasma fractionated metanephrines, 24 hour urine metanephrines 6. OSA > sleep study 7. Aortic Coarctation > CXR, CT-Angio 8. Meds
441
Routine labs in new dx of HTN to determine if secondary cause vs essential HTN
Preliminary: urinalysis, Lytes, FBG and/or A1C, lipids, ECG F/U: Lyts, Cr, FPG/A1C, fasting lipids
442
HTN Treatment Targets: - High-risk pt: ___ - DM: __ - Mod to High risk pt: __ - Low risk pt: __
- High-risk pt: SBP <120 - DM: <130/80 - Mod to High risk pt: <140/90 - Low risk pt: <140/90
443
HTN non-pharm tx involves
Lifestyle modifications and managing RFs
444
HTN pharm options include
o Thiazide/Thiazide-LikeDiuretics–natriuretic and removes salt from arterial wall
 oAngiotensin Converting Enzyme Inhibitor/ACE-I[-pril]–blocks ATII formation (vasoconstrictor) o Angiotensin Receptor Blocker/ARB [- sartan] – blocks angiotensin II receptors
 o Calcium Channel Blocker/CCB [- dipine] – blocks entry of calcium into vascular smooth muscle 
o β-Blocker [- olol] – inhibits sympathetic nervous system response
 o Single Pill Combination – ACE-I/ARB + CCB or ACE-I/ARB + Diuretic not ACE-I + ARB
445
RAAS inhibitors contraindicated in ___, caution for ___ / β-Blocker is not first line for ___
RAAS inhibitors contraindicated in pregnancy, caution for reproductive age / β-Blocker is not first line for 60+
446
For initial antihypertensive therapy, start with ___ or ___
Monotherapy or SPC
447
Patients on antihypertensive drug treatment should be seen every ___, until readings on two consecutive visits are below their target, and then ____ intervals thereafter
Patients on antihypertensive drug treatment should be seen every 1 – 2 months, until readings on two consecutive visits are below their target, and then 3 – 6 month intervals thereafter
448
Thiazide diuretics: Mech-- SEs-- C/I--
• Mechanism – inhibits Na and CL reabsorption in the distal tubule; loss of electrolytes cause increase in urine output (diuretic) reducing fluid and thus BP • Side Effects – hyponatremia, hypokalemia, hyperglycemia, hyperlipidemia, increased uric acid • Contraindications – gout; *caution in diabetes (due to hyperglycemia risk) and dyslipidemia (due hyperlipidemia risk)
449
ACEi: Mech-- SEs-- C/I--
• Mechanism – inhibits ACE (angiotensin converting enzyme), reducing synthesis of vasoconstrictor (ATII) and suppressed aldosterone resulting in natriuresis • Side Effects – cough, hyperkalemia, increased creatinine/AKI, angioedema • Contraindications – pregnancy
450
ARB: Mech-- SEs-- C/I--
* Mechanism – antagonist at ATII (angiotensin II) receptor of vascular muscle * Side Effects – hyperkalemia, increased creatinine/AKI * Contraindications – pregnancy
451
BB: Mech-- SEs-- C/I--
* Mechanism – preferentially blocks β-receptors, decreasing HR and output, decreases renin release * Side Effects – fatigue, bradycardia, hypotension, headaches * Contraindications – asthma, epipen*
452
CCB: Mech-- SEs--
• Mechanism – blocks calcium channels in the heart and smooth muscle; dilates peripheral arterioles and slows AV node conduction • Side Effects – pedal edema, flushing, headaches, AV block